A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
Clinical trial NCT04035668 · TERMINATED
Trial details
- NCT number
- NCT04035668
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-12
- Primary completion
- 2021-11-23
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.